Antenatal screening for Down's syndrome: where are we and where next?
Foundation for Blood Research, Scarborough, ME 04070-0190, USA.
J E
JE
Haddow
D000649:Amniocentesis; D015415:Biomarkers / Q000097:blood; D006063:Chorionic Gonadotropin / Q000097:blood; D002891:Chromosomes, Human, Pair 21 / Q000235:genetics; D004314:Down Syndrome / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000235:genetics / Q000517:prevention & control; D004964:Estriol / Q000097:blood; D005260:Female; D005315:Fetal Diseases / Q000175:diagnosis* / Q000000981:diagnostic imaging / Q000235:genetics / Q000517:prevention & control; D005819:Genetic Markers / Q000235:genetics; D005820:Genetic Testing; D006801:Humans; D007265:Inhibins / Q000097:blood; D008403:Mass Screening; D008423:Maternal Age; D016133:Polymerase Chain Reaction; D011247:Pregnancy / Q000097:blood; D018566:Pregnancy, High-Risk; D011296:Prenatal Diagnosis; D016216:Ultrasonography, Prenatal; D000509:alpha-Fetoproteins / Q000032:analysis
D015415:Biomarkers; D006063:Chorionic Gonadotropin; D005819:Genetic Markers; D000509:alpha-Fetoproteins; D007265:Inhibins; D004964:Estriol